- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 307/52 - Radicaux substitués par des atomes d'azote ne faisant par partie d'un radical nitro
Détention brevets de la classe C07D 307/52
Brevets de cette classe: 549
Historique des publications depuis 10 ans
|
38
|
51
|
40
|
36
|
49
|
29
|
36
|
15
|
28
|
16
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Regents of the University of California | 20137 |
17 |
| ADT Pharmaceuticals, LLC | 13 |
12 |
| Anji Pharmaceuticals Inc. | 34 |
8 |
| Corteva Agriscience LLC | 2692 |
8 |
| King Abdulaziz University | 512 |
7 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2882 |
7 |
| BASF SE | 21039 |
6 |
| Centre National de La Recherche Scientifique | 10576 |
6 |
| Drexel University | 1005 |
6 |
| Mitsubishi Gas Chemical Company, Inc. | 3485 |
6 |
| The United States Government AS represented by The Department of Veterans Affairs | 1210 |
6 |
| Newmarket Pharmaceuticals LLC | 13 |
6 |
| ChemoCentryx, Inc. | 383 |
5 |
| Immunomet Therapeutics Inc. | 31 |
5 |
| Intervet Inc. | 908 |
5 |
| Rhodia Operations | 1586 |
5 |
| Exonate Limited | 15 |
5 |
| Shanghai Leado PharmaTech Co. Ltd. | 16 |
5 |
| Wisconsin Alumni Research Foundation | 3887 |
4 |
| Abbvie Inc. | 1802 |
4 |
| Autres propriétaires | 416 |